e 4031 has been researched along with Cardiomyopathy, Dilated in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veldkamp, MW | 1 |
| van Ginneken, AC | 1 |
| Opthof, T | 1 |
| Bouman, LN | 1 |
1 other study available for e 4031 and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Delayed rectifier channels in human ventricular myocytes.
Topics: Action Potentials; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cells, Cultured; Heart Ventricle | 1995 |